Efficacy of Soya Lecithin Powder Combined with Conventional Therapy on Chronic Hepatitis B

[Objectives]To probe into the treatment effects of soya lecithin powder combined with conventional therapy on chronic hepatitis B.[Methods]A total of 120 patients with chronic hepatitis B admitted to the Eighth People’s Hospital of Guangzhou from February 2017 to February 2018 were randomly divided into observation group and control group in the way of drawing lots,with 60 cases in each group.Both groups of patients were treated with conventional therapy.On this basis,the control group was given Liver Protection Tablet,and the observation group was given soya lecithin powder for 2 months.The relief of symptoms of both groups and the recovery of liver functions were observed,including alanine aminotransferase(ALT),aspartate aminotransferase(AST),serum total bilirubin(TBIL),and glutamyl transpeptidase(GGT),as well as recovery of B-scan ultrasonography image and adverse drug reactions were observed.[Results]After treatment,the relief rate of fatigue,anorexia,abdominal distension and the disappearance rate of hepatic discomfort in the observation group were significant higher than those in the control group,and the difference was statistically significant(P<0.05);the recovery rate of ALT,AST,TBIL and GGT levels in the observation group was higher than that in the control group,and the difference was statistically significant(P<0.05);the recovery rate of B-scan ultrasonography image in the observation group was significantly higher than that in the control group,and the difference was statistically significant(P<0.05).No significant adverse drug reactions were found in two groups during the drug administration.[Conclusions]Soya lecithin powder combined with conventional therapy on chronic hepatitis B can significantly improve the liver function and relieve the symptoms.

大豆磷脂散联合常规治疗用于慢性乙型肝炎的疗效观察

目的:探讨大豆磷脂散联合常规治疗用于慢性乙型肝炎的治疗效果。方法:选取2017年2月至2018年2月广州市第八人民医院收治的慢性乙型肝炎患者120例,按照抽签法随机分为观察组和对照组,每组60例。两组患者均采用常规治疗,在此基础上,对照组患者给予护肝片,观察组患者给予大豆磷脂散,观察时间为2个月。观察两组患者各症状减轻情况、肝功能恢复情况[丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、总胆红素(TBIL)及谷酰转肽酶(GGT)]、B超声像图恢复情况及不良反应发生情况。结果:治疗后,观察组患者的乏力减轻率、纳差减轻率、腹胀减轻率及肝区不适消失率明显高于对照组,差异均有统计学意义(P<0.05);观察组患者的ALT、AST、TBIL及GGT水平恢复正常率明显高于对照组,差异均有统计学意义(P<0.05);观察组患者B超声像图恢复正常率明显高于对照组,差异有统计学意义(P<0.05)。服药期间,两组患者未发现明显不良反应。结论:大豆磷脂散联合常规治疗用于慢性乙型肝炎,可明显改善患者的肝功能、减轻症状。

ICP-AES法测定大豆磷脂粉的磷含量

目的:建立电感耦合等离子体原子发射光谱法(ICP-AES)测定大豆磷脂粉中磷含量的方法。方法:样品采用高氯酸及硝酸消解后进行ICP-AES测定。结果:在0～100mg·mL-1的范围内,线性关系良好,r=0.9999;精密度(RSD)为0.97%,样品的加样回收率在98～102%之间,磷的检出限为34.3μg.L-1。结论:本方法可简单快速地测定大豆磷脂粉中磷的含量,灵敏度好、准确性高。